Oncotarget

Research Papers:

Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon

Yohei Shirakami _, Takahiro Kochi, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Kazuto Yoshimi, Takashi Kuramoto, Takuji Tanaka, Masahito Shimizu and Mitsuru Seishima

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:33972-33981. https://doi.org/10.18632/oncotarget.26119

Metrics: PDF 354 views  |   HTML 816 views  |   ?  


Abstract

Yohei Shirakami1,2, Takahiro Kochi2, Masaya Kubota2, Hiroyasu Sakai2, Takashi Ibuka2, Kazuto Yoshimi3, Takashi Kuramoto4, Takuji Tanaka5, Masahito Shimizu2 and Mitsuru Seishima1

1Department of Informative Clinical Medicine, Gifu University Graduate School of Medicine, Gifu 501–1194, Japan

2Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu 501–1194, Japan

3Genome Editing Research and Development Center, Graduate School of Medicine, Osaka University, Osaka 565–0871, Japan

4Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto 606–8501, Japan

5Department of Pathological Diagnosis, Gifu Municipal Hospital, Gifu 500–8513, Japan

Correspondence to:

Yohei Shirakami, email: ys2443@gifu-u.ac.jp

Keywords: colorectal cancer; pentoxifylline; inflammatory bowel disease (IBD); oxidative stress

Received: March 19, 2018     Accepted: September 04, 2018     Published: September 21, 2018

ABSTRACT

Chronic inflammation in the colorectum increases the risk of colorectal cancer development. Pentoxifylline, a medicine used for improving the circulation, has been reported to inhibit TNF-α production and to ameliorate inflammatory bowel disease and non-alcoholic steatohepatitis. In this study, we investigated the effects of pentoxifylline on inflammation-related colon tumorigenesis in a rodent model using Kyoto APC delta rats, which have APC mutation and are susceptible to colon carcinogenesis. Male Kyoto APC delta rats were treated with azoxymethane and dextran sodium sulfate, and were subsequently administered water, with or without pentoxifylline. At the end of the experiment, the development of colorectal tumor was significantly inhibited in the pentoxifylline group. The pentoxifylline treatment also lowered the levels of oxidative stress markers and mRNAs of pro-inflammatory cytokines, including TNF-α and IL-6, in the colon mucosa. The PCNA labeling index and the inflammation score were also decreased in the colon of rats in the pentoxifylline -treated group. We also used an endoscopy to observe the tumor progression and inflammation in the colon of rats, revealing that inflammation grade was significantly lower in pentoxifylline-treated group at several points during the experiment. These findings suggest that pentoxifylline treatment might be useful for chemoprevention of inflammation-related colon cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26119